Stock Events

Asymchem Laboratories (Tianjin) 

$3.2
0
+$0+0% Wednesday 13:37

Statistik

Tag Hoch
-
Tag Tief
-
52W Hoch
-
52W Niedrig
-
Volumen
-
Durch. Volumen
-
Marktkap.
0
KGV
0
Dividendenrendite
-
Dividende
-

Demnächst

Gewinne

25OctErwartet
Q3 2022
Q1 2023
Q2 2023
Q3 2023
Q1 2024
Q2 2024
Weiter
0
0.94
1.89
2.83
Erwartetes EPS
1.3142766516
Tatsächliches EPS
K.A.

Leute folgen auch

Diese Liste basiert auf den Watchlists von Personen auf Stock Events, die ASLTY folgen. Es handelt sich nicht um eine Anlageempfehlung.

Wettbewerber

Diese Liste ist eine Analyse basierend auf aktuellen Marktereignissen. Es ist keine Anlageempfehlung.

Über

Asymchem Laboratories (Tianjin) Co., Ltd. provides contract development and manufacturing organization services in Mainland China and internationally. The company offers drug research and development, and manufacturing services for pharmaceutical and biotech companies. Its solutions range from early clinical stage to commercial stage, including research and development, and cGMP production of advanced intermediates, active pharmaceutical ingredients, and formulations, as well as clinical research services. The company also engages in the provision of pharmaceutical analysis and testing services; sale, wholesale, and retail of drugs; and pharmaceutical science and technology development activities. It has a collaboration agreement with AUM Biosciences to develop and commercialize AUM 601. The company was founded in 1999 and is headquartered in Tianjin, China. AUM Biosciences.
Show more...
CEO
Dr. Hao Hong Ph.D.
Mitarbeiter
9719
Land
CN
ISIN
US04651E1038

Börsen